Other adult osteomalacia
ICD-10 M83.8 is a billable code used to indicate a diagnosis of other adult osteomalacia.
Other adult osteomalacia refers to a condition characterized by the softening of bones due to inadequate mineralization, primarily calcium and phosphate. This condition can arise from various factors, including vitamin D deficiency, malabsorption syndromes, or chronic kidney disease. Unlike osteoporosis, which involves a reduction in bone density and structural integrity, osteomalacia specifically affects the mineralization process, leading to weakened bones that are more susceptible to deformities and fractures. Patients may present with bone pain, muscle weakness, and an increased risk of fractures, particularly in weight-bearing bones. Diagnosis typically involves clinical evaluation, imaging studies such as X-rays or bone density scans, and laboratory tests to assess vitamin D levels and other metabolic markers. Treatment focuses on addressing the underlying cause, which may include vitamin D supplementation, dietary modifications, and management of any associated conditions. Regular monitoring of bone health is essential to prevent complications associated with this disorder.
Detailed history of metabolic disorders, lab results for vitamin D and calcium levels, and imaging studies.
Patients with chronic kidney disease presenting with bone pain and weakness.
Ensure comprehensive metabolic panel results are included to support diagnosis.
Clinical evaluation of joint and bone pain, history of autoimmune disorders, and relevant imaging.
Patients with autoimmune diseases presenting with bone pain and risk of fractures.
Document any concurrent treatments that may affect bone health.
Used to assess metabolic status in patients suspected of having osteomalacia.
Document all lab results and clinical findings.
Endocrinologists should ensure that all relevant metabolic disorders are evaluated.
Common causes include vitamin D deficiency, malabsorption syndromes, chronic kidney disease, and certain medications that affect bone metabolism.
